Medicare advantage beneficiaries who received care from providers in 2-sided risk payment models had lower rates of acute care use, according to new study findings.
New data published in JAMA Network Open Thursday revealed 2-sided risk models were associated with lower rates of acute care use among Medicare Advantage (MA) beneficiaries, especially for potentially avoidable events.
The study was led by a team at Humana and is based on the insurance plan’s MA members, of whom two-thirds are cared for by a provider in a value-based payment model. The authors said to their knowledge, it is the first peer-reviewed study of value-based payment in MA.
In recent years, Medicare has increasingly shifted away from fee-for-service (FFS) reimbursement models and toward value-based payment structures aimed at rewarding improving quality and controlling spending.
“We've seen far more rapid adoption of value-based models in Medicare Advantage than we have in traditional Medicare, and certainly a lot more than in Medicaid or commercial,” said William Shrank, MD, MSHS, chief medical officer at Humana, in an interview with The American Journal of Managed Care® (AJMC®).
Data from the Learning and Action Network show that in 2020, 58% of MA beneficiaries received care from physicians in value-based arrangements, compared with 43% of those in traditional Medicare, and around 35% each of Medicaid or commercial beneficiaries, Shrank said.
But despite numerous studies evaluating these models in traditional Medicare, less is known about the MA population.
To address this knowledge gap, researchers identified beneficiaries enrolled in the MA organization between January 2017 and December 2019. Individuals were divided based on their attributed primary care organization’s payment model: FFS, shared savings with upside-only financial risk; and shared savings with upside and downside financial risk (2-sided risk).
Claims data were used to identify hospitalizations, observation stays, or emergency department (ED) visits throughout the study window; these were then categorized into avoidable and all-cause events.
The final analysis included a total of 489,796 beneficiaries, of whom 16.6% were in an FFS model, 32.4% in upside-only risk, and 51% in 2-sided risk. Researchers found those in 2-sided risk models had lower rates of all 3 outcomes compared with individuals in FFS models.
Specifically, adjusted analyses showed:
In addition, the link between value-based payment and decreased use was most pronounced for measures of avoidable care, authors wrote—a finding consistent with studies carried out in traditional Medicare settings.
“It’s really compelling…to see reductions in health services use across the board, hospitalizations, observation stays, ED visits, in patients that are cared for in value-based arrangements. But I think it's even more notable how dramatic the reductions are in avoidable health services use, avoidable hospitalizations, avoidable, ED visits,” Shrank stressed.
“It really speaks to the fact that providers participating in risk-based value-based models are doing something meaningfully different. And for patients with complex chronic conditions, they're caring for those patients in a way that really meaningfully reduces their need to be hospitalized or to get acute care. That should be reassuring,” he added.
Due to the study’s retrospective nature, residual confounding may have been present, while it is likely selection bias exists with regard to which primary care organizations engage in value-based payment models.
More natural experiments or additional models examining when patients switch from one type of care to another can help address this bias and are currently being pursued, Shrank said.
However, the lack of differences seen between the FFS and upside-only risk populations suggests downside risk may play a key role in effective value-based payment arrangements, authors wrote.
“I think that once providers take 2-sided risk, they're making a bigger commitment. And that bigger commitment, I believe, is associated with more meaningful investments in the technology, and the care models that are needed to really drive better health outcomes,” Shrank said.
Providers that are committed to taking downside risk are also “making a more intentional set of decisions around how to how to operate their practices to drive better experiences and better health outcomes for patients,” he added.
More research is needed to better understand the actions of value-based primary care organizations associated with reductions in acute care use, authors concluded.
Reference
Gondi S, Li Y, Antol DD, Bourdreau E, Shrank WH, and Powers BW. Analysis of value-based payment and acute care use among medicare advantage beneficiaries. JAMA Netw Open. Published online March 17, 2022. doi:10.1001/jamanetworkopen.2022.2916
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More